Rocket Pharmaceuticals, Inc. Profile Avatar - Palmy Investing

Rocket Pharmaceuticals, Inc.

Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs f…

Biotechnology
US, Cranbury [HQ]
US · Macroeconomic Factors/Risks · Forecasts

Macro

Rocket Pharmaceuticals, Inc. mainly operates in US (Alpha-2: US, Alpha-3: USA)

United States
Analysis Results
B Overall Rating
19 Analyzed Indicators
B Annual Indicators Rating
16 Analyzed Indicators
B+ Monthly Indicators Rating
3 Analyzed Indicators
Breakdown

All indicators comes from high quality sources, such as the world bank, OECD, FRED and manuel datasets such as Premiums by Prof. Damodaran.

End of RCKT's Analysis
CIK: 1281895 CUSIP: 77313F106 ISIN: US77313F1066 LEI: - UEI: -
Secondary Listings
RCKT has no secondary listings inside our databases.